Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Schultz

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Biomedicines|December 23, 2022
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer DrugChristopher W Schultz, Avinoam Nevler
Molecular Cancer Therapeutics|July 13, 2022
CDK7 Inhibition Synergizes with Topoisomerase I Inhibition in Small Cell Lung Cancer Cells by Inducing Ubiquitin-Mediated Proteolysis of RNA Polymerase IIYilun Sun, Yang Zhang, Christopher W Schultz, et al.
Wiley Interdisciplinary Reviews. RNA|January 24, 2020
Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)Christopher W Schultz, Ranjan Preet, Teena Dhir, et al.
Molecular Cancer Therapeutics|November 3, 2019
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic ImplicationsSamantha A Armstrong, Christopher W Schultz, Ariana Azimi-Sadjadi, et al.
Annals of Surgical Oncology|August 12, 2020
Margin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve SurvivalRichard Zheng, David Nauheim, Jonathan Bassig, et al.
BMJ Open|October 17, 2023
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinomaFrancesca M Ponzini, Christopher W Schultz, Benjamin E Leiby, et al.
Cancer Research Communications|November 16, 2022
Replication stress defines distinct molecular subtypes across cancersNobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, et al.
Journal of the American College of Surgeons|February 15, 2020
Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and ProgressionAvinoam Nevler, Samantha Z Brown, David Nauheim, et al.
Computational and Structural Biotechnology Journal|June 30, 2025
SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasmsKolos Nemes, Gabriella Mihalekné Fűr, Alexandra Benő, et al.
Molecular Cancer Therapeutics|May 28, 2021
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging AgentsUkhyun Jo, Ilya S Senatorov, Astrid Zimmermann, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biomedicines|December 23, 2022
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer DrugChristopher W Schultz, Avinoam Nevler
Molecular Cancer Therapeutics|July 13, 2022
CDK7 Inhibition Synergizes with Topoisomerase I Inhibition in Small Cell Lung Cancer Cells by Inducing Ubiquitin-Mediated Proteolysis of RNA Polymerase IIYilun Sun, Yang Zhang, Christopher W Schultz, et al.
Wiley Interdisciplinary Reviews. RNA|January 24, 2020
Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)Christopher W Schultz, Ranjan Preet, Teena Dhir, et al.
Molecular Cancer Therapeutics|November 3, 2019
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic ImplicationsSamantha A Armstrong, Christopher W Schultz, Ariana Azimi-Sadjadi, et al.
Annals of Surgical Oncology|August 12, 2020
Margin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve SurvivalRichard Zheng, David Nauheim, Jonathan Bassig, et al.
BMJ Open|October 17, 2023
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinomaFrancesca M Ponzini, Christopher W Schultz, Benjamin E Leiby, et al.
Cancer Research Communications|November 16, 2022
Replication stress defines distinct molecular subtypes across cancersNobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, et al.
Journal of the American College of Surgeons|February 15, 2020
Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and ProgressionAvinoam Nevler, Samantha Z Brown, David Nauheim, et al.
Computational and Structural Biotechnology Journal|June 30, 2025
SurvSig: Harnessing gene expression signatures to uncover heterogeneity in lung neuroendocrine neoplasmsKolos Nemes, Gabriella Mihalekné Fűr, Alexandra Benő, et al.
Molecular Cancer Therapeutics|May 28, 2021
Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging AgentsUkhyun Jo, Ilya S Senatorov, Astrid Zimmermann, et al.
Pageof 4